Protection against renal disease in (NZB × NZW)F1 lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide
Open Access
- 25 May 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (6), 1945-1953
- https://doi.org/10.1002/art.22700
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Tolerogenic Treatment of Lupus Mice with Consensus Peptide Induces Foxp3-Expressing, Apoptosis-Resistant, TGFβ-Secreting CD8+ T Cell SuppressorsPublished by The American Association of Immunologists ,2005
- SLE: translating lessons from model systems to human diseaseTrends in Immunology, 2005
- Clinical and histopathological progression of lesions in lupus-prone (NZB×NZW) F1 miceExperimental and Toxicologic Pathology, 2004
- Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequencesArthritis & Rheumatism, 2002
- Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupusArthritis & Rheumatism, 2001
- Gene Therapeutic Approaches to Induction and Maintenance of ToleranceInternational Reviews of Immunology, 2001
- The central and multiple roles of B cells in lupus pathogenesisImmunological Reviews, 1999
- Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus.JCI Insight, 1998
- Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotypeCellular Immunology, 1991
- THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSISMedicine, 1971